About US
Contact us
-
Senator questions Pfizer's $2,000-a-month price on XeljanzShould taxpayers enjoy lower drug prices if federal money backed development? At least one U.S. senator thinks so, now that Pfizer ($PFE) has slapped a $2,000-per-month sticker price on the newrheuma2013/3/20
-
Suit suggests Lilly warehouse burglars got hands on security assessmentThe daring heist of $70 million worth of drugs from an Eli Lilly ($LLY) warehouse two years ago rolled out like the script of a movie.The thieves hit a vulnerable spot on the roof, rapelled down rope2013/3/20
-
Novartis nabs EU clearance for Jetrea; Roche's hep C drug Pegasys wins new useNovartis ($NVS) won European approval for its eye drug Jetrea, as a treatment for vitreomacular traction, which can cause progressive and irreversible vision loss. The European Medicines Agency also a2013/3/19
-
National Essential Medicine List (2012 edition) releasedThe National Essential Medicine List (2012 edition) was recently released. The new list consists of three parts: chemical medicines and biological products, Chinese proprietary medicines, and prepare2013/3/19
-
New medical device coating approved for use in JapanNovozymes Biopharma has announced approval in Japan for a medical device using Recombumin Alpha, a recombinant human albumin product. Recombumin Alpha is used by one of the company's customers M2013/3/18
-
MS patients search Internet for info on drugs from Genzyme, NovartisSome patients with multiple sclerosis often attack the Internet for anything new about what drugs are available and what may be next. A survey of so-called health activists by Extrovertic and WEGO Hea2013/3/18
-
FDA ushers in new lymph-node mapper for cancer patientsThe FDA granted its blessing to Lymphoseek, the first new lymph-node mapping drug in more than 30 years. The Navidea Biopharmaceuticals ($NAVB) product uses a receptor-targeted radioactive tracer to2013/3/15
-
FDA scrutinizing Merck's Januvia, BMS' ByettaThe FDA is taking a closer look at the increased risk of Type 2 diabetics getting pancreatic cancer from the popular drugs like Merck's blockbuster Januvia and Byetta from Bristol-Myers Squibb. The2013/3/15
-
Sistemic and Leading CDMO, Progenitor Cell Therapy (PCT) Initiate Study on Novel Stem Cell Characterisation TechnologySistemic Limited (Sistemic), the miRNA profiling company with facilities in Glasgow, Scotland and Boston, announced today the signature of an agreement to allow Progenitor Cell Therapy (PCT), Mountai2013/3/14
-
Pfizer's popular 'Z-Pak' carries increased fatal risk for some, FDA saysThe "Z-Pak" is a convenient and so a popular antibiotic treatment that doctors prescribe for everything from ear infections to pneumonia. But in case anybody missed it earlier, the FDA wants to make2013/3/14